Twice-weekly SubQ vs. once-weekly IM injections: which is right for you?

When most people imagine testosterone therapy, they picture a monthly clinic visit and a large intramuscular injection. That model exists — but it is not the standard of care we recommend at Pure Metabolics, and understanding why requires a brief explanation of what happens in the body when hormone levels spike and fall.

What happens with a weekly IM injection.

Intramuscular testosterone injected once weekly produces a significant peak in serum testosterone in the 24–48 hours after injection, followed by a progressive decline over the rest of the week. By day six or seven, many men are operating near or below their pre-treatment baseline. The result is a hormonal roller coaster: high energy and mood on days one and two, gradually declining function toward the end of the week, and a noticeable low point before the next injection.

For some men, this weekly fluctuation is tolerable. For others, it causes meaningful variability in energy, mood, libido, and cognitive clarity — none of which are desirable in a therapy that is supposed to improve those very things.

The goal of TRT is stable, physiological hormone levels — not weekly peaks and troughs that swing your mood and energy with them.

The case for twice-weekly SubQ.

Twice-weekly subcutaneous injections — delivered into the fat just beneath the skin using a small insulin-style needle — solve the variability problem directly. By dividing the weekly dose into two smaller injections, the peaks are lower and the troughs are higher. Hormone levels stay within a narrower, more stable range throughout the week.

The clinical advantages are meaningful:

• Steadier mood and energy: No pronounced mid-week drop in testosterone levels means fewer of the mood and energy fluctuations that come with single weekly dosing.
• Lower DHT peaks: Smaller testosterone spikes mean less conversion to DHT at the peak — relevant for men concerned about hair loss or prostate health.
• Lower estrogen surges: With smaller peaks, aromatase conversion to estrogen is more gradual, often reducing the need for estrogen management agents.
• Easier injections: SubQ injections use a much smaller needle than IM. Most patients describe the technique as far less intimidating than traditional intramuscular delivery once they are shown how.

When IM may still be the right choice.

Once-weekly IM is not without merit. Some men genuinely prefer the simplicity of a single weekly injection and tolerate the hormone variability without noticeable effect. For patients on certain ester formulations with longer half-lives, IM can produce adequate stability on a weekly schedule. And for men who travel frequently or have difficulty with twice-weekly adherence, a simpler protocol that gets done consistently outperforms a better protocol that doesn't.

The right answer depends on your physiology, your lifestyle, and your response to therapy — which is why we review these variables at every lab cycle and adjust accordingly.

Disclaimer: Injection protocols are individually prescribed based on lab results, symptom response, and clinical assessment. Do not adjust your own dosing schedule without consulting your clinician.